Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy: Part A
- 1st Edition, Volume 165 - June 4, 2025
- Latest edition
- Editors: Arun Kumar Singh, Neeraj Mishra, Sumel Ashique, Pranav Kumar Prabhakar
- Language: English
Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy, Volume 165 in the Advances in Immunology series, presents current developments and comprehensive reviews in DN… Read more
Description
Description
Other chapters cover mRNA-Based Cancer Vaccines: A Novel Approach to Melanoma Treatment, Therapeutic mRNAs for cancer immunotherapy: from structure to delivery, Harnessing the immune system: Insights into cancer vaccines, Lipid Nanoparticle-Mediated mRNA Delivery in Cancer Immunotherapy, Immunotherapy Perspectives in the Era of B-Cell Editing in Cancer Treatment, Personalized Precision: Revolutionizing Cancer Treatment with mRNA-Based Vaccines in Melanoma Therapy, Revolutionizing Cancer Treatment: Exploring Novel Immunotherapeutics, Checkpoints, bispecifics, and Vaccines in Development, and more.
Key features
Key features
- Presents current developments and comprehensive reviews in immunology
- Provides the latest in a longstanding and respected serial on the subject matter
- Focuses on recent advances in the field of immunology
Readership
Readership
Table of contents
Table of contents
1. DNA and mRNA vaccines: Significant therapeutic approach against cancer management
Aniruddha Sen, Vijay Singh, Sumel Ashique, Jagriti, Sombuddha Biswas, Anas Islam,
Iman Ehsan, and Naheed Mojgani
2. Nucleic acid delivery as a therapeutic approach for cancer immunotherapy
Kashish Wilson, Garima, and Meenakshi Dhanawat
3. Plasmid DNA and mRNA Delivery: Approaches and Challenges
Arun Kumar Singh, Karan Goel, and Meenakshi Dhanawat
4. Viral & non-viral delivery of mRNA against cancer
Ece Guler, Humeyra Betul Yekeler, Muhammet Emin Cam, and Burcu Uner
5. Progress in modifying and elivering mRNA therapies for cancer immunotherapy
Karan Goel, Isha Chawla, Garima, Meenakshi Dhanawat, and Pramila Chaubey
6. mRNA-based cancer vaccines: A novel approach to melanoma treatment
Pranav Kumar Prabhakar, Tarun Kumar, Upadhyaya, and
Sanjeev Kumar Sahu
7. Therapeutic mRNAs for cancer immunotherapy: From structure to delivery
Monika Vishwakarma, Wasim Akram, and Tanweer Haider
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 165
- Published: June 18, 2025
- Language: English
About the editors
About the editors
AS
Arun Kumar Singh
NM
Neeraj Mishra
Dr. Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Gwalior. He has over 20 years of teaching and research experience in pharmaceutics, with particular expertise in novel drug delivery systems, localized and targeted drug delivery, and nanocarrier-based therapeutics for disease. His formulations and controlled delivery approaches are aimed at improving therapeutic outcomes. Dr. Mishra has supervised postgraduate and doctoral research scholars, has contributed widely to academic literature through research publications, books, and book chapters with leading international publishers. He has won several awards including Outstanding Scientist Award, and Distinguished Professor Award. He is associated with innovation in pharmaceutical sciences through patented research contributions. Over the course of his career, he has received several academic and scientific recognitions for his contributions to teaching, and research. He has been recognized internationally for his research impact and scholarly contributions.
SA
Sumel Ashique
PP
Pranav Kumar Prabhakar
Dr. Pranav Kumar Prabhakar is currently working as a Professor and Head at Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India. He is among the World’s Top 2% Scientists (list published by Stanford University, USA, 2021, 2022, 2023, 2024, and 2025). He completed his PhD in Biotechnology from IIT Madras. His research focuses on elucidating molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders (diabetes) using natural products. Dr. Pranav is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. He serves as an editorial board member and reviewer for many reputed national and international journals. His honors include a travel grant from IIT Madras and the Council for Scientific and Industrial Research (CSIR) to attend ATTD 2009 in Greece, approved by the Department of Science and Technology (DST). He has published over 160+ research articles, authored/edited 24 books, and 48 book chapters, and delivered 9 oral and poster presentations at scientific meetings.